In this task, you are given text for US Congressional and California state bills, your task is to generate a summary for this bill.

Q: SECTION 1. DEVELOPMENT OF BEST PRACTICES FOR THE USE OF PRESCRIPTION 
              OPIOIDS.

    (a) Definitions.--In this section--
            (1) the term ``Secretary'' means the Secretary of Health 
        and Human Services; and
            (2) the term ``task force'' means the Pain Management Best 
        Practices Inter-Agency Task Force convened under subsection 
        (b).
    (b) Inter-Agency Task Force.--Not later than December 14, 2018, the 
Secretary, in cooperation with the Secretary of Veterans Affairs, the 
Secretary of Defense, and the Administrator of the Drug Enforcement 
Administration, shall convene a Pain Management Best Practices Inter-
Agency Task Force to review, modify, and update, as appropriate, best 
practices for pain management (including chronic and acute pain) and 
prescribing pain medication.
    (c) Membership.--The task force shall be comprised of--
            (1) representatives of--
                    (A) the Department of Health and Human Services;
                    (B) the Department of Veterans Affairs;
                    (C) the Food and Drug Administration;
                    (D) the Department of Defense;
                    (E) the Drug Enforcement Administration;
                    (F) the Centers for Disease Control and Prevention;
                    (G) the Health Resources and Services 
                Administration;
                    (H) the Indian Health Service;
                    (I) the National Academy of Medicine;
                    (J) the National Institutes of Health;
                    (K) the Office of National Drug Control Policy;
                    (L) the Substance Abuse and Mental Health Services 
                Administration; and
                    (M) the Office of Women's Health;
            (2) State medical boards;
            (3) subject to subsection (e), physicians, dentists, and 
        nonphysician prescribers;
            (4) hospitals;
            (5) subject to subsection (e), pharmacists and pharmacies;
            (6) first responders;
            (7) experts in the fields of pain research and addiction 
        research;
            (8) experts in the fields of adolescent and young adult 
        addiction research;
            (9) representatives of--
                    (A) pain management professional organizations;
                    (B) the mental health treatment community;
                    (C) the addiction treatment and recovery community;
                    (D) pain advocacy groups;
                    (E) veteran service organizations; and
                    (F) groups with expertise on overdose reversal;
            (10) a person in recovery from addiction to medication for 
        chronic pain;
            (11) a person in recovery from addiction to medication for 
        chronic pain, whose addiction began in adolescence or young 
        adulthood;
            (12) a person with chronic pain;
            (13) an expert on active duty military, armed forces 
        personnel, and veteran health and prescription opioid 
        addiction;
            (14) an expert in the field of minority health; and
            (15) other stakeholders, as the Secretary determines 
        appropriate.
    (d) Condition on Participation on Task Force.--An individual 
representing a profession or entity described in paragraph (3) or (5) 
of subsection (c) may not serve as a member of the task force unless 
such individual--
            (1) is currently licensed in a State in which such 
        individual is practicing (as defined by such State) such 
        profession (or, in the case of an individual representing an 
        entity, a State in which the entity is engaged in business); 
        and
            (2) is currently practicing (as defined by such State) such 
        profession (or, in the case of an individual representing an 
        entity, the entity is in operation).
    (e) Duties.--The task force shall--
            (1) not later than 180 days after the date on which the 
        task force is convened under subsection (b), review, modify, 
        and update, as appropriate, best practices for pain management 
        (including chronic and acute pain) and prescribing pain 
        medication, taking into consideration--
                    (A) existing pain management research;
                    (B) research on trends in areas and communities in 
                which the prescription opioid abuse rate and fatality 
                rate exceed the national average prescription opioid 
                abuse rate and fatality rate;
                    (C) recommendations from relevant conferences and 
                existing relevant evidence-based guidelines;
                    (D) ongoing efforts at the State and local levels 
                and by medical professional organizations to develop 
                improved pain management strategies, including 
                consideration of differences within and between classes 
                of opioids, the availability of opioids with abuse 
                deterrent technology, and pharmacological, 
                nonpharmacological, medical device alternatives to 
                opioids to reduce opioid monotherapy in appropriate 
                cases and the coordination of information collected 
                from State prescription drug monitoring programs for 
                the purpose of preventing the diversion of pain 
                medication;
                    (E) ongoing efforts at the Federal, State, and 
                local levels to examine the potential benefits of 
                electronic prescribing of opioids, including any public 
                comments collected in the course of those efforts;
                    (F) the management of high-risk populations, other 
                than populations who suffer pain, who--
                            (i) may use or be prescribed 
                        benzodiazepines, alcohol, and diverted opioids; 
                        or
                            (ii) receive opioids in the course of 
                        medical care;
                    (G) the distinct needs of adolescents and young 
                adults with respect to pain management, pain 
                medication, substance use disorder, and medication-
                assisted treatment;
                    (H) the 2016 Guideline for Prescribing Opioids for 
                Chronic Pain issued by the Centers for Disease Control 
                and Prevention;
                    (I) the practice of co-prescribing naloxone for 
                both pain patients receiving chronic opioid therapy and 
                patients being treated for opioid use disorders;
                    (J) research that has been, or is being, conducted 
                or supported by the Federal Government on prevention 
                of, treatment for, and recovery from substance use by 
                and substance use disorders among adolescents and young 
                adults relative to any unique circumstances (including 
                social and biological circumstances) of adolescents and 
                young adults that may make adolescent-specific and 
                young adult-specific treatment protocols necessary, 
                including any effects that substance use and substance 
                use disorders may have on brain development and the 
                implications for treatment and recovery;
                    (K) Federal non-research programs and activities 
                that address prevention of, treatment for, and recovery 
                from substance use by and substance use disorders among 
                adolescents and young adults, including an assessment 
                of the effectiveness of such programs and activities 
                in--
                            (i) preventing substance use by and 
                        substance use disorders among adolescents and 
                        young adults;
                            (ii) treating such adolescents and young 
                        adults in a way that accounts for any unique 
                        circumstances faced by adolescents and young 
                        adults; and
                            (iii) supporting long-term recovery among 
                        adolescents and young adults; and
                    (L) gaps that have been identified by Federal 
                officials and experts in Federal efforts relating to 
                prevention of, treatment for, and recovery from 
                substance use by and substance use disorders among 
                adolescents and young adults, including gaps in 
                research, data collection, and measures to evaluate the 
                effectiveness of Federal efforts, and the reasons for 
                such gaps;
            (2) solicit and take into consideration public comment on 
        the practices developed under paragraph (1), amending such best 
        practices if appropriate;
            (3) develop a strategy for disseminating information about 
        the best practices developed under paragraphs (1) and (2) to 
        prescribers, pharmacists, State medical boards, educational 
        institutions that educate prescribers and pharmacists, and 
        other parties, as the Secretary determines appropriate;
            (4) review, modify, and update best practices for pain 
        management and prescribing pain medication, specifically as it 
        pertains to physician education and consumer education; and
            (5) examine and identify--
                    (A) the extent of the need for the development of 
                new pharmacological, nonpharmacological, and medical 
                device alternatives to opioids;
                    (B) the current status of research efforts to 
                develop such alternatives; and
                    (C) the pharmacological, nonpharmacological, and 
                medical device alternatives to opioids that are 
                currently available that could be better utilized.
    (f) Consideration of Study Results.--In reviewing, modifying, and 
updating, best practices for pain management and prescribing pain 
medication, the task force shall take into consideration existing 
private sector, State, and local government efforts related to pain 
management and prescribing pain medication.
    (g) Limitation.--The task force shall not have rulemaking 
authority.
    (h) Report.--Not later than 270 days after the date on which the 
task force is convened under subsection (b), the task force shall 
submit to Congress a report that includes--
            (1) the strategy for disseminating best practices for pain 
        management (including chronic and acute pain) and prescribing 
        pain medication, as developed under subsection (e);
            (2) the results of a feasibility study on linking the best 
        practices described in paragraph (1) to receiving and renewing 
        registrations under section 303(f) of the Controlled Substances 
        Act (21 U.S.C. 823(f));
            (3) recommendations for effectively applying the best 
        practices described in paragraph (1) to improve prescribing 
        practices at medical facilities, including medical facilities 
        of the Veterans Health Administration and Indian Health 
        Service;
            (4) the modified and updated best practices described in 
        subsection (e)(4); and
            (5) the results of the examination and identification 
        conducted pursuant to subsection (e)(4), and recommendations 
        regarding--
                    (A) the development of new pharmacological, 
                nonpharmacological, and medical device alternatives to 
                opioids; and
                    (B) the improved utilization of pharmacological, 
                nonpharmacological, and medical device alternatives to 
                opioids that are currently available.

            Passed the House of Representatives May 11, 2016.

            Attest:

                                                 KAREN L. HAAS,

                                                                 Clerk.

A: (Sec. 1) This bill requires the Department of Health and Human Services to convene a Pain Management Best Practices Inter-Agency Task Force to: (1) review, modify, and update best practices for pain management and prescribing pain medication; and (2) examine and identify the need for, development of, and availability of medical alternatives to opioids (drugs with effects similar to opium, such as certain pain medications). The task force must submit a report that includes: (1) the modified and updated best practices; (2) a strategy for disseminating the best practices; (3) the feasibility of linking the best practices to Drug Enforcement Administration registration of manufacturers, distributors, and dispensers of controlled substances; (4) recommendations for effectively applying the best practices at medical facilities; and (5) recommendations regarding medical alternatives to opioids.
****
Q: SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Safe and Reliable Air Travel Act of 
2013''.

SEC. 2. FINDINGS.

    Congress finds the following:
            (1) Sequestration is having a devastating effect on the 
        Nation's air traffic control system.
            (2) Sequestration imposes a reduction in funding of $637 
        million on the Federal Aviation Administration (FAA) for the 
        remainder of fiscal year 2013.
            (3) The FAA plans to furlough the vast majority of the 
        FAA's nearly 47,000 employees, including nearly 15,000 air 
        traffic controllers, for approximately one day during each two-
        week pay period in order to comply with sequestration.
            (4) The furloughs began on Sunday, April 21, 2013, and are 
        scheduled to continue through the end of the fiscal year on 
        September 30, 2013. Approximately 10 percent of the FAA's air 
        traffic controllers are expected to be on furlough on any given 
        day during this period.
            (5) The furloughs are causing hundreds of flights to be 
        delayed, resulting in scheduling difficulties for airlines and 
        inconveniences for passengers.
            (6) The FAA reported that approximately 400 flights were 
        delayed nationwide on April 21, 2013, as a result of the 
        furloughs.
            (7) The FAA reported that more than 1,200 flights were 
        delayed nationwide on April 22, 2013, as a result of the 
        furloughs.
            (8) More delays are expected in the coming months during 
        the peak summer travel season.
            (9) The effects of multiple flight delays at airports 
        across the Nation can be compounded as delays at one airport 
        cause planes to arrive late at other airports and also cause 
        passengers to miss connecting flights.
            (10) Air carriers operating in United States air space 
        transport more than 700 million passengers every year.
            (11) Civil aviation accounts for 10 million jobs, is 
        responsible for more than 5 percent of the United States gross 
        domestic product, and contributes $1.3 trillion to the economy 
        every year.
            (12) Businesses of all sizes depend upon a reliable 
        commercial air transportation system. Business travelers 
        account for millions of trips each month.
            (13) Flight delays for business travelers interfere with 
        business plans and result in business meetings being delayed, 
        cancelled, or missed.
            (14) Flight delays affecting the transportation of air 
        cargo also interfere with business.
            (15) The Nation's economy depends upon a reliable 
        commercial air transportation system.
            (16) The FAA also plans to close 149 air traffic control 
        towers at small airports across the Nation on June 15, 2013, in 
        order to comply with sequestration. Despite their size, these 
        airports are an important part of the Nation's air 
        transportation system and economy.
            (17) Air traffic control is a critical government function 
        that is necessary to ensure the safety of air travel and the 
        flying public.
            (18) Inadequate staffing of airport control towers poses a 
        serious threat to public safety.
            (19) Without the service of experienced air traffic 
        controllers in all of the Nation's Federal air traffic control 
        towers, there is an increased risk of accidents involving 
        planes during departure, flight, and landing. Such accidents 
        could result in a tragic loss of life.
            (20) The sequestration of funds associated with the 
        operation of air traffic control towers by the FAA interferes 
        with the safety, reliability, and efficiency of the Nation's 
        air transportation system.
            (21) The operation of air traffic control towers by the 
        FAA, including the compensation paid to air traffic control 
        personnel employed by the FAA, should be exempted from 
        sequestration.

SEC. 3. EXEMPTION FROM SEQUESTRATION FOR OPERATION OF AIR TRAFFIC 
              CONTROL TOWERS.

    (a) In General.--Section 255 of the Balanced Budget and Emergency 
Deficit Control Act of 1985 (2 U.S.C. 905) is amended by adding at the 
end the following new subsection:
    ``(k) Operation of Air Traffic Control Towers.--The following funds 
shall be exempt from reduction under any order issued under this part:
            ``(1) Funds made available for the operation of air traffic 
        control towers by the Federal Aviation Administration, 
        including compensation paid to air traffic control personnel 
        employed by the Federal Aviation Administration.
            ``(2) Funds made available for the operation of contract 
        air traffic control towers under section 47124 of title 49, 
        United States Code.''.
    (b) Effective Date.--The amendment made by section 1 shall apply to 
the Presidential sequestration order for fiscal year 2013 issued under 
section 251A of the Balanced Budget and Emergency Deficit Control Act 
of 1985 (2 U.S.C. 901a) and any subsequent sequestration order issued 
under that Act.

A: Safe and Reliable Air Travel Act of 2013 - Amends the Balanced Budget and Emergency Deficit Control Act of 1985 (Gramm-Rudman-Hollings Act) to exempt from reduction, under any sequestration ordered by the President, funds made available for the operation of: (1) air traffic control towers by the Federal Aviation Administration (FAA), including compensation paid to FAA air traffic control personnel; and (2) contract air traffic control towers.
****
Q: SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Energy and Revenue Enrichment Act of 
2011''.

SEC. 2. DEFINITIONS.

    In this Act:
            (1) Department.--The term ``Department'' means the 
        Department of Energy.
            (2) Enrichment plant.--The term ``enrichment plant'' means 
        a uranium enrichment plant owned by the Department of Energy 
        with respect to which the Nuclear Regulatory Commission has 
        made a determination of compliance under section 1701(b)(2) of 
        the Atomic Energy Act of 1954 (42 U.S.C. 2297f(b)(2)).
            (3) Qualified operator.--The term ``qualified operator'' 
        means a company that has experience in operating an enrichment 
        plant under Nuclear Regulatory Commission authorization and has 
        the ability and workforce to enrich the depleted uranium that 
        is owned by the Department of Energy.
            (4) Reenrichment.--The term ``reenrichment'' means 
        increasing the weight percent of U-235 in uranium in order to 
        make the uranium usable.
            (5) Secretary.--The term ``Secretary'' means the Secretary 
        of Energy.

SEC. 3. REENRICHMENT CONTRACT.

    (a) In General.--
            (1) Requirement.--The Secretary shall enter into a contract 
        with a qualified operator for a 24-month pilot program for the 
        reenrichment at an enrichment plant of the depleted uranium 
        described in section 2(3) that the Secretary finds economically 
        viable. The Secretary shall seek to maximize the financial 
        return to the Federal Government in negotiating the terms of 
        such contract.
            (2) Amount of enrichment.--The Secretary shall, during each 
        year of the pilot program under this subsection, conduct 
        uranium reenrichment under such program in an amount (measured 
        in separative work units) equal to approximately 25 percent of 
        the aggregate uranium enrichment conducted in the United States 
        during calendar year 2010.
            (3) Economic viability.--For purposes of paragraph (1), 
        uranium shall be considered economically viable if the cost to 
        the United States of the reenrichment thereof, including the 
        costs of the contract entered into under paragraph (1), are 
        less than the revenue anticipated from the sale of the 
        reenriched uranium.
    (b) Commencement of Reenrichment Activities.--Reenrichment 
activities under the contract entered into under subsection (a) shall 
commence as soon as possible, but no later than June 1, 2012.
    (c) Sale of Reenriched Uranium.--The Secretary may from time to 
time sell the reenriched uranium generated pursuant to the contract 
entered into under subsection (a).
    (d) Allocation and Use of Proceeds.--Any funds received by the 
Secretary from the sale of reenriched uranium generated pursuant to the 
contract entered into under subsection (a) shall be allocated as 
follows:
            (1) First, such funds shall be available to the Secretary, 
        without further appropriation and without fiscal year 
        limitation, to carry out this section, including amounts 
        required to be paid under the contract entered into under 
        subsection (a).
            (2) Any amounts not required for the purposes described in 
        paragraph (1) shall be transferred to the Uranium Enrichment 
        Decontamination and Decommissioning Fund established in section 
        1801 of the Atomic Energy Act of 1954 (42 U.S.C. 2297g), to be 
        available for use, without further appropriation and without 
        fiscal year limitation.

SEC. 4. DEPLETED URANIUM.

    (a) Title and Responsibility for Disposition.--The Secretary shall 
assume title to, and responsibility for the disposition of, all 
depleted uranium generated pursuant to the contract entered into under 
section 3(a).
    (b) Funding for Reenrichment.--To provide funding for payments 
under the contract entered into under section 3(a), the Secretary may--
            (1) assume title to, and responsibility for the disposition 
        of, depleted uranium in addition to the depleted uranium 
        specified in subsection (a); and
            (2) transfer to the qualified operator title to uranium 
        generated as a result of the reenrichment pursuant to the 
        contract entered into under section 3(a).

SEC. 5. LIMITATION ON FEDERAL URANIUM SALES.

    (a) Initial Period.--Notwithstanding section 3112(d) of the USEC 
Privatization Act (42 U.S.C. 2297h-10(d)), during the 24-month pilot 
program and the subsequent 24 months after that program is complete, 
the Secretary may not during any calendar year sell an amount of 
uranium that exceeds 15 percent of the United States' domestic uranium 
supply for that year.
    (b) Subsequent Period.--After the expiration of the 48-month period 
described in subsection (a), the Secretary may not during any calendar 
year sell an amount of uranium that exceeds 10 percent of the United 
States' domestic uranium supply for that year, except to the extent 
that the Secretary determines that such sales will have no significant 
effect on uranium markets.

A:
Energy and Revenue Enrichment Act of 2011 - Directs the Secretary of Energy (DOE) to contract with a qualified operator for a 24-month pilot program for the reenrichment at an enrichment plant of certain depleted uranium, beginning no later than June 1, 2012.

Authorizes the Secretary to sell the reenriched uranium generated under the contract and allocate the proceeds according to a certain scheme.

Directs the Secretary to assume title to, and responsibility for, the disposition of depleted uranium so generated.

Prohibits the Secretary from selling, each year during the pilot program and the subsequent 24 months after program completion, an amount of uranium exceeding 15% of the U.S. domestic uranium supply. Prohibits the sale of more than 10% of the U.S. domestic uranium supply during any year after such 48-month period, unless such sales will have no significant effect on uranium markets.
****